We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Illustration of green microscopic bacteria and viruses.
Industry Insight

Harnessing the Immune System To Combat Antimicrobial Resistance

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.
A researcher holding up a hologram of a molecule in a pill, representing AI-driven anti-infective discovery.
Industry Insight

Anti-Infective Development Boosted by AI and Automation

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.
Illustration of the gut on sky blue background with various bacteria inside it, representing the gut microbiome.
Industry Insight

A Nutrient-Based Alternative to Weight Loss Drugs

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.
A person walking past a comb-shaped structure with glowing cells and particles in the bays and bright squares on the floor.
Industry Insight

Making Single-Cell Functional Analysis Accessible to All

Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.
Hand holding a small wooden cube with a green tick, symbolizing verification, surrounded by vegetation.
Industry Insight

Funding Will Advance Third-Party Verified Sustainability in Science

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Illustration of a female scientist analyzing gut microbiome bacteria to study gut health.
Industry Insight

The Probiotic Designed To Work When Your Gut Is Under Attack

Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.
A tick on a green leaf with water droplets.
Industry Insight

Tick-Borne Illness Diagnosis Enters New Era With Multiplex Testing

Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.
Syringe needle inserted into vaccine vial.
Industry Insight

DNA Vaccines Offer a New Path Beyond mRNA Technology

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine development.
A man in a mask recieving a vaccine, a crucial part of pandemic preparedness.
Industry Insight

T-Cell Priming Technology Strengthens Pandemic Preparedness

Technology Networks spoke to Professor Thomas Rademacher, co-founder, executive director and CEO at Gylden Pharma Limited, to learn more about T-cell priming vaccine technology and its potential to strengthen preparedness for future pandemics.
A pair of glasses and ball point pen laying on top of a folded newspaper with the headline "Research & Development".
Industry Insight

Why Good Science Is Key to Good Technology

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.
Advertisement